The healthcare industry is under a lot of pressure to reduce the cost of care delivery while improving patient outcomes. This is because healthcare expenditures have become unsustainable. To address this challenge, payers, providers, and regulators are pushing for greater efficiency and value in healthcare. As a result, there’s growing investor interest in emerging healthcare […]
Read More… from Investing in Healthcare Tech to Reduce Costs
The paediatric mental health sector is expanding rapidly, presenting a great opportunity to become one of the most promising markets in healthcare. The rise in childhood depression, anxiety, ADHD, and autism spectrum disorders is driving this growth. The market is projected to increase from $383.31 billion in 2020 to $537.97 billion by 2030. Although North […]
The global CRISPR gene editing market was valued at over $1 billion in 2021 and is predicted to reach USD 14.80 billion by 2030, increasing at a CAGR of 29.80% from 2022 to 2030. This dramatic rise comes from a growing prevalence of genetic diseases globally, increasing applications of gene editing in various industries and […]
Despite decreased global M&A activity in 2022, Healthcare deal flow has remained high in 2022 and is expected to increase as long established large-cap pharmaceutical players continue to invest in high-growth biotech companies which are the forefront in various areas of innovation such as gene therapy, mRNA technology and more while simultaneously divesting out of […]
The healthcare sector is becoming more and more important for investors/dealmakers who are evolving their criteria to meet the popularly growing ESG framework through increased due diligence processes and business models. Investing in Healthcare has allowed investors to help fund the creation of critical vaccines, support the treatment of rare-disease treatments while also enjoying the […]
Read More… from Healthcare and ESG Investing. A Perfect Match